Depression
December 25th, 2008 at 06:00am
Under Depression
Anyone will tell you that stress is bad for the heart. Many people also know about the toxic effects of anxiety and depression. But how exactly do these negative emotions cripple the cardiovascular system - and what can be done about it? New research published in the December 16/23, 2008, issue of the Journal of the American College of Cardiology (JACC) offers some answers.
Spread the Love & Syndicate
By
December 24th, 2008 at 06:00am
Under Depression
Medical students frequently suffer from depression, especially during their internship years. New research published in the open access journal BMC Medical Education reveals the extent of the problem and features a detailed analysis of the symptoms and sufferers. Sergio Baldassin, from the ABC Regional Medical School, Brazil, led a team of researchers who carried out a study on 481 medical students in the private medical school near the São Paulo state capital.
Spread the Love & Syndicate
By
December 24th, 2008 at 06:00am
Under Depression
Scientific studies now support what herbal medical practitioners have long known - St. John’s wort is an effective treatment for major depression. “Overall, we found that the St. John’s wort extracts tested in the (29) trials were superior to placebos and as effective as standard antidepressants, with fewer side effects,” says lead researcher, Klaus Linde, of the Centre for Complementary Medicine in Munich, Germany. However, combining St.
Spread the Love & Syndicate
By
December 23rd, 2008 at 06:00am
Under Depression
Leading researchers and clinicians from the field of neuromodulation assembled today at the 12th annual meeting of the North American Neuromodulation Society (NANS), continuing until December 7 in Las Vegas, NV.
Spread the Love & Syndicate
By
December 22nd, 2008 at 06:00am
Under Depression
Scientific studies now support what herbal medical practitioners have long known - St. John’s wort is an effective treatment for major depression. “Overall, we found that the St. John’s wort extracts tested in the (29) trials were superior to placebos and as effective as standard antidepressants, with fewer side effects,” says lead researcher, Klaus Linde, of the Centre for Complementary Medicine in Munich, Germany. However, combining St.
Spread the Love & Syndicate
By
December 22nd, 2008 at 06:00am
Under Depression
Postpartum depression (PPD) can lead to poor sleep quality, recent research shows. A study published in the current issue of the Journal of Obstetric, Gynecologic, & Neonatal Nursing shows that depression symptoms worsen in PPD patients when their quality of sleep declines. Sleep deprivation can hamper a mother’s ability to care for her infant, as judgment and concentration decline.
Spread the Love & Syndicate
By
December 21st, 2008 at 06:00am
Under Depression
Many of the service members who experience traumatic brain injuries in Iraq and Afghanistan are at risk for long-term health problems such as depression and dementia, but it is unknown how high those risks are, according to an Institute of Medicine report released Thursday, the
Spread the Love & Syndicate
By
December 18th, 2008 at 06:00am
Under Depression
Consumers are burying their heads in the sand when it comes to Christmas spending during the credit crunch, a top psychologist is cautioning. Salford University’s Dr Tom Fawcett associates the psychological phenomenon of ‘cognitive dissonance’ - or conflicting thoughts - for the public’s desire to spend this Christmas - even though they know they can’t afford it.
Spread the Love & Syndicate
By
December 16th, 2008 at 06:00am
Under Depression
IMPAX Laboratories, Inc. announced that the U.S. Food and Drug Administration (FDA) granted final approval of the Company’s Abbreviated New Drug Application (ANDA) for a generic version of Wellbutrin® XL 150 mg Extended-release Tablets on Wednesday, November 26, 2008. GlaxoSmithKline markets Wellbutrin® XL for the management of depression. IMPAX’s Global Pharmaceuticals division launched the product immediately following approval.
Spread the Love & Syndicate
By
December 14th, 2008 at 06:00am
Under Depression
.New data suggest that Cymbalta (duloxetine HCl) 60 mg to 120 mg once daily delayed the onset of a new episode of depression in patients who had previously responded to the medication and who had recurrent depressive disorder, defined in the study as those patients who experienced at least three depressive episodes in the previous five years, compared with placebo (p
Spread the Love & Syndicate
By
Next Posts
Previous Posts
